Stattin P - Search Results

1

Diabetes mellitus and prostate cancer risk; a nationwide case-control study within PCBaSe Sweden.

Fall K, Garmo H, Gudbjörnsdottir S, Stattin P, Zethelius B. Fall K, et al. Among authors: stattin p. Cancer Epidemiol Biomarkers Prev. 2013 Jun;22(6):1102-9. doi: 10.1158/1055-9965.EPI-12-1046. Epub 2013 Apr 11. Cancer Epidemiol Biomarkers Prev. 2013. PMID: 23580698 Clinical Trial.

2

Circulating enterolactone and prostate cancer risk: a Nordic nested case-control study.

Stattin P, Adlercreutz H, Tenkanen L, Jellum E, Lumme S, Hallmans G, Harvei S, Teppo L, Stumpf K, Luostarinen T, Lehtinen M, Dillner J, Hakama M. Stattin P, et al. Int J Cancer. 2002 May 1;99(1):124-9. doi: 10.1002/ijc.10313. Int J Cancer. 2002. PMID: 11948503

3

Plasma leptin is not associated with prostate cancer risk.

Stattin P, Kaaks R, Johansson R, Gislefoss R, Söderberg S, Alfthan H, Stenman UH, Jellum E, Olsson T. Stattin P, et al. Cancer Epidemiol Biomarkers Prev. 2003 May;12(5):474-5. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 12750247 No abstract available.

4

Population-based study of prostate-specific antigen testing and prostate cancer detection in clinical practice in northern Sweden.

Pilebro B, Johansson R, Damber L, Damber JE, Stattin P. Pilebro B, et al. Among authors: stattin p. Scand J Urol Nephrol. 2003;37(3):210-2. doi: 10.1080/00365590310008064. Scand J Urol Nephrol. 2003. PMID: 12775278

5

Plasma insulin, IGF-binding proteins-1 and -2 and risk of colorectal cancer: a prospective study in northern Sweden.

Palmqvist R, Stattin P, Rinaldi S, Biessy C, Stenling R, Riboli E, Hallmans G, Kaaks R. Palmqvist R, et al. Among authors: stattin p. Int J Cancer. 2003 Oct 20;107(1):89-93. doi: 10.1002/ijc.11362. Int J Cancer. 2003. PMID: 12925961

6

Plasma leptin and colorectal cancer risk: a prospective study in Northern Sweden.

Stattin P, Palmqvist R, Söderberg S, Biessy C, Ardnor B, Hallmans G, Kaaks R, Olsson T. Stattin P, et al. Oncol Rep. 2003 Nov-Dec;10(6):2015-21. Oncol Rep. 2003. PMID: 14534736

7

High levels of circulating testosterone are not associated with increased prostate cancer risk: a pooled prospective study.

Stattin P, Lumme S, Tenkanen L, Alfthan H, Jellum E, Hallmans G, Thoresen S, Hakulinen T, Luostarinen T, Lehtinen M, Dillner J, Stenman UH, Hakama M. Stattin P, et al. Int J Cancer. 2004 Jan 20;108(3):418-24. doi: 10.1002/ijc.11572. Int J Cancer. 2004. PMID: 14648709

8

Non-systematic screening for prostate cancer in Sweden--survey from the National Prostate Cancer Registry.

Stattin P, Johansson R, Damber JE, Hellström M, Hugosson J, Lundgren R, Varenhorst E, Johansson JE. Stattin P, et al. Scand J Urol Nephrol. 2003;37(6):461-5. doi: 10.1080/00365590310015778. Scand J Urol Nephrol. 2003. PMID: 14675917

9

-160C/A polymorphism in the E-cadherin gene promoter and risk of hereditary, familial and sporadic prostate cancer.

Jonsson BA, Adami HO, Hägglund M, Bergh A, Göransson I, Stattin P, Wiklund F, Grönberg H. Jonsson BA, et al. Among authors: stattin p. Int J Cancer. 2004 Apr 10;109(3):348-52. doi: 10.1002/ijc.11629. Int J Cancer. 2004. PMID: 14961571 Clinical Trial.

10

High levels of circulating insulin-like growth factor-I increase prostate cancer risk: a prospective study in a population-based nonscreened cohort.

Stattin P, Rinaldi S, Biessy C, Stenman UH, Hallmans G, Kaaks R. Stattin P, et al. J Clin Oncol. 2004 Aug 1;22(15):3104-12. doi: 10.1200/JCO.2004.10.105. J Clin Oncol. 2004. PMID: 15284261

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

523 results

Search Page

Filters